Module II: Cardiology CME Evaluation

I have been a practicing clinician for: *

Please indicate which of the following best describes your specialty: *

Please select the extent to which you agree/disagree that the activity supported the achievement of each learning objectives? *

	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
Recognize the role of endothelial dysfunction, nitric oxide, angiotensin II, and aldosterone in atherosclerosis, CHD and CVD	Recognize the role of endothelial dysfunction, nitric oxide, angiotensin II, and aldosterone in atherosclerosis, CHD and CVD - Strongly Disagree	Recognize the role of endothelial dysfunction, nitric oxide, angiotensin II, and aldosterone in atherosclerosis, CHD and CVD - Disagree	Recognize the role of endothelial dysfunction, nitric oxide, angiotensin II, and aldosterone in atherosclerosis, CHD and CVD - Neutral	Recognize the role of endothelial dysfunction, nitric oxide, angiotensin II, and aldosterone in atherosclerosis, CHD and CVD - Agree	Recognize the role of endothelial dysfunction, nitric oxide, angiotensin II, and aldosterone in atherosclerosis, CHD and CVD - Strongly Agree
Recognize how inflammation, oxidative stress, and vascular immune dysfunction promote CVD and CHD	Recognize how inflammation, oxidative stress, and vascular immune dysfunction promote CVD and CHD - Strongly Disagree	Recognize how inflammation, oxidative stress, and vascular immune dysfunction promote CVD and CHD - Disagree	Recognize how inflammation, oxidative stress, and vascular immune dysfunction promote CVD and CHD - Neutral	Recognize how inflammation, oxidative stress, and vascular immune dysfunction promote CVD and CHD - Agree	Recognize how inflammation, oxidative stress, and vascular immune dysfunction promote CVD and CHD - Strongly Agree
Become familiar with the pathways of vascular aging, pathogenesis, and how they relate to the prevention and treatment of atherosclerosis, CHD and CVD	Become familiar with the pathways of vascular aging, pathogenesis, and how they relate to the prevention and treatment of atherosclerosis, CHD and CVD - Strongly Disagree	Become familiar with the pathways of vascular aging, pathogenesis, and how they relate to the prevention and treatment of atherosclerosis, CHD and CVD - Disagree	Become familiar with the pathways of vascular aging, pathogenesis, and how they relate to the prevention and treatment of atherosclerosis, CHD and CVD - Neutral	Become familiar with the pathways of vascular aging, pathogenesis, and how they relate to the prevention and treatment of atherosclerosis, CHD and CVD - Agree	Become familiar with the pathways of vascular aging, pathogenesis, and how they relate to the prevention and treatment of atherosclerosis, CHD and CVD - Strongly Agree
Evaluate the underlying causes and mechanisms of dyslipidemia and dyslipidemia-induced cardiovascular Disease	Evaluate the underlying causes and mechanisms of dyslipidemia and dyslipidemia-induced cardiovascular Disease - Strongly Disagree	Evaluate the underlying causes and mechanisms of dyslipidemia and dyslipidemia-induced cardiovascular Disease - Disagree	Evaluate the underlying causes and mechanisms of dyslipidemia and dyslipidemia-induced cardiovascular Disease - Neutral	Evaluate the underlying causes and mechanisms of dyslipidemia and dyslipidemia-induced cardiovascular Disease - Agree	Evaluate the underlying causes and mechanisms of dyslipidemia and dyslipidemia-induced cardiovascular Disease - Strongly Agree
Identify and apply advanced lipid testing (lipid particle number and size and HDL functionality and quality) for the diagnosis and treatment of dyslipidemia in clinical practice	Identify and apply advanced lipid testing (lipid particle number and size and HDL functionality and quality) for the diagnosis and treatment of dyslipidemia in clinical practice - Strongly Disagree	Identify and apply advanced lipid testing (lipid particle number and size and HDL functionality and quality) for the diagnosis and treatment of dyslipidemia in clinical practice - Disagree	Identify and apply advanced lipid testing (lipid particle number and size and HDL functionality and quality) for the diagnosis and treatment of dyslipidemia in clinical practice - Neutral	Identify and apply advanced lipid testing (lipid particle number and size and HDL functionality and quality) for the diagnosis and treatment of dyslipidemia in clinical practice - Agree	Identify and apply advanced lipid testing (lipid particle number and size and HDL functionality and quality) for the diagnosis and treatment of dyslipidemia in clinical practice - Strongly Agree

If you answered "Strongly Disagree" or "Disagree" please explain:

Please select the extent to which you agree/disagree that the activity achieved the following: *

	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
The content was evidence-based	The content was evidence-based - Strongly Disagree	The content was evidence-based - Disagree	The content was evidence-based - Neutral	The content was evidence-based - Agree	The content was evidence-based - Strongly Agree
The educational material provided useful information for my practice	The educational material provided useful information for my practice - Strongly Disagree	The educational material provided useful information for my practice - Disagree	The educational material provided useful information for my practice - Neutral	The educational material provided useful information for my practice - Agree	The educational material provided useful information for my practice - Strongly Agree
The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity)	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) - Strongly Disagree	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) - Disagree	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) - Neutral	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) - Agree	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) - Strongly Agree

If you answered "Strongly Disagree" or "Disagree" please explain:

To what degree did/will this activity: *

	Significantly	Moderately	Minimally	Not at all
Increase your knowledge	Increase your knowledge - Significantly	Increase your knowledge - Moderately	Increase your knowledge - Minimally	Increase your knowledge - Not at all
Change your competence	Change your competence - Significantly	Change your competence - Moderately	Change your competence - Minimally	Change your competence - Not at all
Change your practice performance	Change your practice performance - Significantly	Change your practice performance - Moderately	Change your practice performance - Minimally	Change your practice performance - Not at all
Change patient care	Change patient care - Significantly	Change patient care - Moderately	Change patient care - Minimally	Change patient care - Not at all

Do you plan to implement & utilize the information you have received at this course? *

Yes

No

If you answered "No", please explain:

Was this activity free of commercial bias? *

Yes

No

If you answered "No", please explain:

Please rate the faculty *

	Excellent	Above Average	Average	Fair	Poor
Deanna Minich, PhD	Deanna Minich, PhD - Excellent	Deanna Minich, PhD - Above Average	Deanna Minich, PhD - Average	Deanna Minich, PhD - Fair	Deanna Minich, PhD - Poor
Filomena Trindade, MD, MPH	Filomena Trindade, MD, MPH - Excellent	Filomena Trindade, MD, MPH - Above Average	Filomena Trindade, MD, MPH - Average	Filomena Trindade, MD, MPH - Fair	Filomena Trindade, MD, MPH - Poor
Jill Carnahan, MD	Jill Carnahan, MD - Excellent	Jill Carnahan, MD - Above Average	Jill Carnahan, MD - Average	Jill Carnahan, MD - Fair	Jill Carnahan, MD - Poor
Stephen Sinatra, MD	Stephen Sinatra, MD - Excellent	Stephen Sinatra, MD - Above Average	Stephen Sinatra, MD - Average	Stephen Sinatra, MD - Fair	Stephen Sinatra, MD - Poor
Mark Houston, MD	Mark Houston, MD - Excellent	Mark Houston, MD - Above Average	Mark Houston, MD - Average	Mark Houston, MD - Fair	Mark Houston, MD - Poor

Please feel free to comment on any aspect of this activity. (Optional)

Specific to your specialty, what other topics would be beneficial in your practice for future educational activities?

Specific to your specialty, what other topics would be beneficial in your practice for future educational activities? Other...

I prefer to receive CME through: *

I prefer to receive CME through: Other...

The George Washington University School of Medicine and Health Sciences